Invitation to Roche’s 3rd Quarter Sales 2020 Webinar Mittwoch, 16. September 2020 - 10:17

Invitation to Roche's 3rd Quarter Sales 2020 Webinar

Roche will publish its Sales Results for the 3rd Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, October 15th, 2020.

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

• Severin Schwan, CEO Roche Group
• Bill Anderson, CEO Roche Pharmaceuticals
• Thomas Schinecker, CEO Roche Diagnostics
• Alan Hippe, Chief Financial and IT Officer
  
  
  

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*

A replay of the webcast will be available via > ir.roche.com
*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations

Roche Investor Relations

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com

Investor Relations North America

Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com

Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com